Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
130.6 USD | -0.05% | +2.71% | +14.21% |
Apr. 22 | RBC Capital Adjusts Xylem Price Target to $157 From $153 | MT |
Apr. 18 | Oppenheimer Adjusts Price Target on Xylem to $142 From $133, Outperform Rating Kept | MT |
Financials (USD)
Sales 2024 * | 8.5B | Sales 2025 * | 8.97B | Capitalization | 31.59B |
---|---|---|---|---|---|
Net income 2024 * | 823M | Net income 2025 * | 985M | EV / Sales 2024 * | 3.8 x |
Net Debt 2024 * | 703M | Net Debt 2025 * | 105M | EV / Sales 2025 * | 3.53 x |
P/E ratio 2024 * |
38.8
x | P/E ratio 2025 * |
32.8
x | Employees | 23,000 |
Yield 2024 * |
1.1% | Yield 2025 * |
1.18% | Free-Float | 93.17% |
Latest transcript on Xylem Inc.
1 day | -0.05% | ||
1 week | +2.71% | ||
Current month | +1.06% | ||
1 month | +2.23% | ||
3 months | +15.60% | ||
6 months | +48.83% | ||
Current year | +14.21% |
Managers | Title | Age | Since |
---|---|---|---|
Matthew Pine
CEO | Chief Executive Officer | 52 | 20-02-29 |
William Grogan
DFI | Director of Finance/CFO | 45 | 23-09-30 |
David Flinton
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Loranger
BRD | Director/Board Member | 72 | 11-10-30 |
Lisa Glatch
BRD | Director/Board Member | 61 | 23-05-23 |
Robert Friel
CHM | Chairman | 68 | 12-12-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.28% | 10 M€ | +6.14% | - | |
0.97% | 1 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 130.6 | -0.05% | 963,557 |
24-04-24 | 130.7 | -0.04% | 1,053,013 |
24-04-23 | 130.7 | +1.35% | 945,656 |
24-04-22 | 129 | +0.89% | 1,061,915 |
24-04-19 | 127.8 | +0.53% | 2,250,015 |
Delayed Quote Nyse, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.21% | 31.59B | |
+9.08% | 82.5B | |
+19.25% | 70.16B | |
+18.99% | 37.32B | |
+7.43% | 28.13B | |
+3.50% | 26.77B | |
+2.06% | 26.3B | |
+14.45% | 24.99B | |
+16.45% | 23.55B | |
+16.04% | 16.48B |
- Stock Market
- Equities
- XYL Stock